Bolt Biotherapeutics 10% owner Coastlands Capital bought 50,000 common shares at $6.38 each, raising indirect beneficial ownership to 462,416 shares.

Observed price moves

• BOLT+4.35%10 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.